Chinese COVID-19 Trial Approaching End

Chinese COVID-19 Trial Approaching End

A United Arab Emirates company, Group42 or G42, is nearing the end of phase 3 clinical trials for a Chinese COVID-19 vaccine. They are hoping to start producing in the masses next year. This potential vaccine was a product of the partnership between G42, an Abu-Dhabi...
How AI is Changing the Face of Translation

How AI is Changing the Face of Translation

As the demand for quality affordable translations is ever increasing, companies are increasingly harnessing artificial intelligence (AI),  moving beyond traditional translation memory and terminology management systems. When using artificial intelligence (AI) for...